Genetic Analysis strengthens its management team by hiring a Head of Operations
OSLO, NORWAY – 4 March 2022: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company has strengthened its management team by hiring Mr. Lars Tiller as Head of Operations. Lars Tiller will be responsible for manufacturing and logistics activities in GA.
As a result of the increased market demand for the GA-map diagnostic kits, GA has now strengthened its organisation with expertise and know-how from scale-up in the fast-growing diagnostic industry. As Head of Operations, Mr. Lars Tiller will be responsible for manufacturing and logistics and will focus on production efficiency to secure that the Company is able to meet future manufacturing capacity in a cost-efficient way.
CEO of Genetic Analysis, Ronny Hermansen, comments:
“We are happy to announce that Mr. Lars Tiller has joined GA. He brings with him strong experience from various management roles in the fast-growing diagnostic industry, among others from Alere Technologies (now a part of Abbott Diagnostics) where he has led manufacturing teams with a strong focus on cost-efficient production, scale-up and automated processes. We welcome Lars to our management team and will value his knowledge and input in the exciting commercialisation phase of GA”.
For further information, please contact:
Ronny Hermansen, Chief Executive Officer
E-mail: rh@genetic-analysis.com
About Genetic Analysis:
Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map® platform is based on a pre-determined multiplex targets approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to help unlocking and restoring the human microbiome through its state-of-the-art technology. GA employs 24 highly qualified employees with relevant scientific backgrounds and with competence in bioinformatics, molecular biology, and bioengineering. www.genetic-analysis.com
Tags: